Behind the Science
Today: #120 in Science, Japan on our combined chart.
Chart positions today · United States
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Behind the Science, try…
Ranking history · United States
Latest episodes
-
Can science change the future of hepatitis B?
October 9, 2026 · 25 minExperts Joyeta Das & Jessica Hicks discuss a disease that is so quiet and unassuming, it's often called 'the silent disease’ – Hepatitis B. Developed and funded by GSK. Show note: In the third Behind the Science episode, Dr. Kat…
-
If 400m+ people live with COPD, why aren’t we talking about it?
July 21, 2026 · 28 minExperts Kaivan Khavandi and Dave Singh discuss diseases that affect a fundamental aspect of life – breathing. Developed and funded by GSK. Show note: In the second Behind the Science episode, Dr. Kat Arney speaks with Professor Dave…
-
Introducing: If 400m+ people live with COPD, why aren’t we talking about it?
July 13, 2026 · 1 minKaivan Khavandi & Dave Singh discuss a disease that affects a fundamental aspect of life – breathing. Episode coming soon. Developed and funded by GSK.
-
Are we turning the tide on superbugs?
January 26, 2026 · 33 minExperts David Payne and Alison Holmes explore one of today’s biggest health challenges - antimicrobial resistance. Developed and funded by GSK. Show note: In the first Behind the Science episode, Dr. Kat Arney speaks with Professor…
-
Introducing: Are we turning the tide on superbugs?
January 20, 2026 · 1 minDavid Payne & Alison Holmes explore one of the biggest health challenges: antimicrobial resistance. Episode coming soon. Developed and funded by GSK

Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom